Sandro Vivona

Dr. Sandro Vivona

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2015 in Nature
Verified
Journal Article
Closed access
PDF file
Jiajie DiaoJiajie Diao
Jiajie Diao
RLRong Liu
Rong Liu
YRYueguang Rong
Yueguang Rong
MZMinglei Zhao
Minglei Zhao
JZJing Zhang
Jing Zhang
QING ZHONGQING ZHONG
QING ZHONG

12 January 2015 in Nature
Verified
Journal Article
Open access
PDF file
MZMinglei Zhao
Minglei Zhao
SWShenping Wu
Shenping Wu
QZQiangjun Zhou
Qiangjun Zhou
Sandro VivonaSandro Vivona
Sandro Vivona
DCDaniel J. Cipriano
Daniel J. Cipriano
ABAxel T. Brunger
Axel T. Brunger
Evolutionarily conserved SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptors) proteins form a complex that drives membrane fusion in eukaryotes. The ATPase NSF (N-ethylmaleimide sensitive factor), together with SNAPs (soluble NSF attachment protein), disassembles the SNARE complex into its protein components, making individual SNAREs available for subsequent rounds of fusion. Here we report structures of ATP- and ADP-bound NSF, and the NSF/SNAP/SNARE (20S) supercomplex determined by single-particle electron cryomicroscopy at near-atomic to sub-nanometre resolution without imposing symmetry. Large, potentially force-generating, conformational differences exist between ATP- and ADP-bound NSF. The 20S supercomplex exhibits broken symmetry, transitioning from six-fold symmetry of the NSF ATPase domains to pseudo four-fold symmetry of the SNARE complex. SNAPs interact with the SNARE complex with an opposite structural twist, suggesting an unwinding mechanism. The interfaces between NSF, SNAPs, and SNAREs exhibit characteristic electrostatic patterns, suggesting how one NSF/SNAP species can act on many different SNARE complexes.

12 June 2013 in Nature
Verified
Journal Article
Closed access
PDF file
JBJacqueline Burré
Jacqueline Burré
Sandro VivonaSandro Vivona
Sandro Vivona
Jiajie DiaoJiajie Diao
Jiajie Diao
MSManu Sharma
Manu Sharma
ABAxel T. Brunger
Axel T. Brunger
TSThomas C. Südhof
Thomas C. Südhof

30 April 2013 in eLife
Verified
Journal Article
Open access
Jiajie DiaoJiajie Diao
Jiajie Diao
JBJacqueline Burré
Jacqueline Burré
Sandro VivonaSandro Vivona
Sandro Vivona
DCDaniel J Cipriano
Daniel J Cipriano
MSManu Sharma
Manu Sharma
ABAxel T Brunger
Axel T Brunger
α-Synuclein is a presynaptic protein that is implicated in Parkinson's and other neurodegenerative diseases. Physiologically, native α-synuclein promotes presynaptic SNARE-complex assembly, but its molecular mechanism of action remains unknown. Here, we found that native α-synuclein promotes clustering of synaptic-vesicle mimics, using a single-vesicle optical microscopy system. This vesicle-clustering activity was observed for both recombinant and native α-synuclein purified from mouse brain. Clustering was dependent on specific interactions of native α-synuclein with both synaptobrevin-2/VAMP2 and anionic lipids. Out of the three familial Parkinson's disease-related point mutants of α-synuclein, only the lipid-binding deficient mutation A30P disrupted clustering, hinting at a possible loss of function phenotype for this mutant. α-Synuclein had little effect on Ca2+-triggered fusion in our reconstituted single-vesicle system, consistent with in vivo data. α-Synuclein may therefore lead to accumulation of synaptic vesicles at the active zone, providing a ‘buffer’ of synaptic vesicles, without affecting neurotransmitter release itself.

18 July 2006 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
Sandro VivonaSandro Vivona
Sandro Vivona
FBFilippo Bernante
Filippo Bernante
FFFrancesco Filippini
Francesco Filippini
Background: Since a milestone work on Neisseria meningitidis B, Reverse Vaccinology has strongly enhanced the identification of vaccine candidates by replacing several experimental tasks using in silico prediction steps. These steps have allowed scientists to face the selection of antigens from the predicted proteome of pathogens, for which cell culture is difficult or impossible, saving time and money. However, this good example of bioinformatics-driven immunology can be further developed by improving in silico steps and implementing biologist-friendly tools. Results: We introduce NERVE (New Enhanced Reverse Vaccinology Environment), an user-friendly software environment for the in silico identification of the best vaccine candidates from whole proteomes of bacterial pathogens. The software integrates multiple robust and well-known algorithms for protein analysis and comparison. Vaccine candidates are ranked and presented in a html table showing relevant information and links to corresponding primary data. Information concerning all proteins of the analyzed proteome is not deleted along selection steps but rather flows into an SQL database for further mining and analyses. Conclusion: After learning from recent years' works in this field and analysing a large dataset, NERVE has been implemented and tuned as the first available tool able to rank a restricted pool (~8–9% of the whole proteome) of vaccine candidates and to show high recall (~75–80%) of known protective antigens. These vaccine candidates are required to be "safe" (taking into account autoimmunity risk) and "easy" for further experimental, high-throughput screening (avoiding possibly not soluble antigens). NERVE is expected to help save time and money in vaccine design and is available as an additional file with this manuscript; updated versions will be available at http://www.bio.unipd.it/molbinfo.

1 December 2012 in Developmental Cell
Verified
Journal Article
Closed access
DDDara P. Dowlatshahi
Dara P. Dowlatshahi
VSVirginie Sandrin
Virginie Sandrin
Sandro VivonaSandro Vivona
Sandro Vivona
TSThomas A. Shaler
Thomas A. Shaler
SKStephen E. Kaiser
Stephen E. Kaiser
RKRon R. Kopito
Ron R. Kopito